Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Regeneron Pharmaceuticals, Inc.

NASDAQ: REGN · Life Sciences · 13 alerts · CIK 872589

Share price
$952.40Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Regeneron Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:02 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals SVP Controller Jason Pitofsky Sells $3.83M of Stock

Jason Pitofsky, SVP Controller, sold 4,062 shares of Regeneron Pharmaceuticals, Inc. at $939.57 to $950.76 a share (average $942.19) in 8 transactions, worth $3.83M in total on Nov 4, 2026. Shares held after the trade: 0 (-100.0%).

Value
$3.83M
Shares
4,062
Average price
$942.19
Role
SVP Controller
Holding change
-100.0%
Trade date
Nov 4, 2026
4:06 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals Insider Huda Y. Zoghbi Sells $7.22M of Stock

Huda Y. Zoghbi sold 7,439 shares of Regeneron Pharmaceuticals, Inc. at $970.42 to $971.06 a share (average $970.46) in 2 transactions, worth $7.22M in total on Nov 3, 2026. Shares held after the trade: 1,703 (-22.7%).

Value
$7.22M
Shares
7,439
Average price
$970.46
Holding change
-22.7%
Trade date
Nov 3, 2026
4:12 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals Insider George L. Sing Sells $20.4M of Stock

George L. Sing sold 21,129 shares of Regeneron Pharmaceuticals, Inc. at $960.57 to $970.18 a share (average $964.38) in 9 transactions, worth $20.4M in total on Nov 2, 2026. Shares held after the trade: 25,147 (-0.8%).

Value
$20.4M
Shares
21,129
Average price
$964.38
Holding change
-0.8%
Trade date
Nov 2, 2026
4:10 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals Insider Christine A. Poon Sells $7.59M of Stock

Christine A. Poon sold 7,830 shares of Regeneron Pharmaceuticals, Inc. at $966.74 to $971.31 a share (average $969.09) in 6 transactions, worth $7.59M in total on Nov 2, 2026. Shares held after the trade: 5,219 (-3.7%).

Value
$7.59M
Shares
7,830
Average price
$969.09
Holding change
-3.7%
Trade date
Nov 2, 2026
4:05 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals EVP General Counsel and Secret Joseph J. Larosa Sells $4.31M of Stock

Joseph J. Larosa, EVP General Counsel and Secret, sold 4,466 shares of Regeneron Pharmaceuticals, Inc. at $965.41 to $966.11 a share (average $965.49) in 2 transactions, worth $4.31M in total on Nov 2, 2026. Shares held after the trade: 38,906 (-1.3%).

Value
$4.31M
Shares
4,466
Average price
$965.49
Role
EVP General Counsel and Secret
Holding change
-1.3%
Trade date
Nov 2, 2026
4:23 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals Insider Kathryn Guarini Sells $360K of Stock

Kathryn Guarini sold 400 shares of Regeneron Pharmaceuticals, Inc. at $900.00 a share, worth $360K in total on Oct 30, 2026. Shares held after the trade: 603 (-39.9%).

Value
$360K
Shares
400
Price
$900.00
Holding change
-39.9%
Trade date
Oct 30, 2026
4:05 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals Insider Michael S. Brown Sells $1.69M of Stock

Michael S. Brown sold 1,929 shares of Regeneron Pharmaceuticals, Inc. at $875.00 a share, worth $1.69M in total on Oct 30, 2026. Shares held after the trade: 1,380 (-58.3%).

Value
$1.69M
Shares
1,929
Price
$875.00
Holding change
-58.3%
Trade date
Oct 30, 2026
4:03 PM ET Form 4
Insider Selling

Regeneron Pharmaceuticals EVP Commercial Marion McCourt Sells $984K of Stock

Marion McCourt, EVP Commercial, sold 1,132 shares of Regeneron Pharmaceuticals, Inc. at $869.43 a share, worth $984K in total on Oct 30, 2026. Shares held after the trade: 10,871 (-9.4%).

Value
$984K
Shares
1,132
Price
$869.43
Role
EVP Commercial
Holding change
-9.4%
Trade date
Oct 30, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.